Figure 1: DPP4 inhibitor group shows improvements in endothelial damage, glycemic control, and microalbuminuria. Non-inhibitor group shows no remarkable changes in these markers. Statistical differences in the alteration rates of each marker between DPP4 inhibitor and noninhibitor groups are recognized in SDF1α, TM, HbA1C, 8-OHdG, eGFR, and ACR. Horizontal bar express standard deviation in each column.